[Factors of resistance of ovarian cancer to combined chemotherapy with the use of platinum derivatives]. - Suppr | 超能文献

[Factors of resistance of ovarian cancer to combined chemotherapy with the use of platinum derivatives].

作者信息

Bliumenberg A G, Gorbacheva L B, Gorbunova V A, Kozachenko V P, Lankin V Z

出版信息

Biull Eksp Biol Med. 1996 Dec;122(12):651-4.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Factors of resistance of ovarian cancer to combined chemotherapy with the use of platinum derivatives].

Biull Eksp Biol Med. 1996 Dec;122(12):651-4.

2

Association between single nucleotide polymorphisms of drug resistance-associated genes and response to chemotherapy in advanced ovarian cancer.晚期卵巢癌耐药相关基因单核苷酸多态性与化疗反应的相关性

Anticancer Res. 2006 May-Jun;26(3B):2227-32.

3

CD44 expression indicates favorable prognosis in epithelial ovarian cancer.CD44表达提示上皮性卵巢癌预后良好。

Clin Cancer Res. 2003 Nov 1;9(14):5318-24.

4

A phase I study of oral topotecan and pegylated liposomal doxorubicin (doxil) in platinum-resistant ovarian and peritoneal cancer.口服拓扑替康与聚乙二醇化脂质体阿霉素（多美素）用于铂耐药卵巢癌和腹膜癌的I期研究。

Am J Clin Oncol. 2008 Oct;31(5):476-80. doi: 10.1097/COC.0b013e31816a6221.

5

WT-1 in ovarian and endometrioid serous carcinoma: a meta-analysis.WT-1在卵巢和子宫内膜样浆液性癌中的meta分析。

Histopathology. 2005 Apr;46(4):468. doi: 10.1111/j.1365-2559.2004.02005.x.

6

Immunohistochemical expression of topoisomerase IIalpha (Topo IIalpha) and multidrug resistance-associated protein (MRP), plus chemosensitivity testing, as chemotherapeutic indices of ovarian and endometrial carcinomas.拓扑异构酶IIα（Topo IIα）和多药耐药相关蛋白（MRP）的免疫组化表达，以及化疗敏感性测试，作为卵巢癌和子宫内膜癌的化疗指标。

Anticancer Res. 2001 Jul-Aug;21(4B):2925-32.

7

Cisplatin sensitivity of ovarian cancer in the histoculture drug response assay correlates to clinical response to combination chemotherapy with cisplatin, doxorubicin and cyclophosphamide.在组织培养药物反应试验中，卵巢癌对顺铂的敏感性与顺铂、阿霉素和环磷酰胺联合化疗的临床反应相关。

Anticancer Res. 2000 May-Jun;20(3B):2049-54.

8

Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant.复发性低级别浆液性卵巢癌对化疗相对耐药。

Gynecol Oncol. 2009 Jul;114(1):48-52. doi: 10.1016/j.ygyno.2009.03.001. Epub 2009 Apr 10.

9

Over-expression of LAPTM4B is associated with poor prognosis and chemotherapy resistance in stages III and IV epithelial ovarian cancer.LAPTM4B 的过表达与 III 期和 IV 期上皮性卵巢癌的不良预后和化疗耐药相关。

J Surg Oncol. 2011 Jul 1;104(1):29-36. doi: 10.1002/jso.21912. Epub 2011 Mar 17.

10

[Application of ATP-tumor chemosensitivity assay in primary epithelial ovarian cancer].ATP肿瘤药敏试验在原发性上皮性卵巢癌中的应用

Zhonghua Zhong Liu Za Zhi. 2010 May;32(5):368-72.

引用本文的文献

1

Cetuximab potentiates oxaliplatin cytotoxic effect through a defect in NER and DNA replication initiation.西妥昔单抗通过核苷酸切除修复（NER）缺陷和DNA复制起始增强奥沙利铂的细胞毒性作用。

Br J Cancer. 2008 Jan 15;98(1):120-8. doi: 10.1038/sj.bjc.6604134. Epub 2008 Jan 8.